Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising anti-cancer therapeutic
S. L. Ranasinghe, G. M. Boyle, K. Fischer, J. Potriquet, J. P. Mulvenna, D. P. McManus
This study identifies EgKI-1, a protease inhibitor from Echinococcus granulosus, as a potential anti-cancer agent that inhibits cancer cell growth and migration in vitro and reduces tumor growth in vivo.
bioRxiv · Jun 27, 2018Cancer Biology